Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMASE: Safety of House Dust Mite SLIT-tablet in Adolescents
NCT04541004Phase 3Completed
- Sponsor
- ALK-Abelló
- Start
- Sep 2020
- Primary completion
- Apr 2021
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 3
01
Overview
A Phase 3 trial of SQ SLIT-tablet in allergic rhinitis (AR), allergic rhinoconjunctivitis (ARC), sponsored by ALK-Abelló. Started Sep 2020; status: completed.
02
Drugs
SQ SLIT-tablet
03
Conditions
allergic rhinitis (AR)allergic rhinoconjunctivitis (ARC)
Beyond the preview
Go deeper on NCT04541004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04541004.